Show simple item record

dc.contributor.authorBarros, Claudia
dc.contributor.authorNguyen, T
dc.contributor.authorSpencer, KSR
dc.contributor.authorNishiyama, A
dc.contributor.authorColognato, H
dc.contributor.authorMüller, U
dc.date.accessioned2016-10-26T21:31:27Z
dc.date.available2016-10-26T21:31:27Z
dc.date.issued2009-08-15
dc.identifier.issn0950-1991
dc.identifier.issn1477-9129
dc.identifier.urihttp://hdl.handle.net/10026.1/6645
dc.description.abstract

<jats:p>Oligodendrocytes in the central nervous system (CNS) produce myelin sheaths that insulate axons to ensure fast propagation of action potentials. β1 integrins regulate the myelination of peripheral nerves, but their function during the myelination of axonal tracts in the CNS is unclear. Here we show that genetically modified mice lacking β1 integrins in the CNS present a deficit in myelination but no defects in the development of the oligodendroglial lineage. Instead, in vitro data show that β1 integrins regulate the outgrowth of myelin sheaths. Oligodendrocytes derived from mutant mice are unable to efficiently extend myelin sheets and fail to activate AKT(also known as AKT1), a kinase that is crucial for axonal ensheathment. The inhibition of PTEN, a negative regulator of AKT, or the expression of a constitutively active form of AKT restores myelin outgrowth in culturedβ1-deficient oligodendrocytes. Our data suggest that β1 integrins play an instructive role in CNS myelination by promoting myelin wrapping in a process that depends on AKT.</jats:p>

dc.format.extent2717-2724
dc.format.mediumPrint
dc.languageen
dc.language.isoeng
dc.publisherThe Company of Biologists
dc.subjectbeta 1 integrins
dc.subjectMyelination
dc.subjectOligodendrocytes
dc.subjectMouse
dc.titleβ1 integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, N.I.H., Extramural
dc.typeResearch Support, Non-U.S. Gov't
dc.typeResearch Support, U.S. Gov't, Non-P.H.S.
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000268312800005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue16
plymouth.volume136
plymouth.publication-statusPublished
plymouth.journalDevelopment
dc.identifier.doi10.1242/dev.038679
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeEngland
dc.identifier.eissn1477-9129
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1242/dev.038679
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review
plymouth.oa-locationhttp://cshperspectives.cshlp.org/content/3/1/a005108.full.pdf+html


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV